Biochemical and structural studies of the prion protein polymorphism

被引:23
作者
Petchanikow, C
Saborio, GP
Anderes, L
Frossard, MJ
Olmedo, MI
Soto, C
机构
[1] Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
[2] Univ Chile, Fac Ciencias, Dept Biol, Millenium Inst Adv Studies Cell Biol & Biotechnol, Santiago, Chile
关键词
prion; transmissible spongiform encephalopathy; protein structure; Creutzfeldt-Jakob disease; circular dichroism;
D O I
10.1016/S0014-5793(01)03147-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A hallmark event in transmissible spongiform encephalopathies is the conversion of the physiological prion protein into the disease-associated isoform. A natural polymorphism at codon 129 of the human prion gene, resulting in either methionine or valine, has profound influence on susceptibility and phenotypic expression of the disease in humans. In this study, we investigated the local propensity of synthetic peptides, corresponding to the region of the polymorphism and containing either methionine or valine, to adopt a beta -sheet-rich structure similar to the pathological protein. Circular dichroism studies showed that the methionine-containing peptide has a greater propensity to adopt a beta -sheet conformation in a variety of experimental conditions. The higher beta -sheet tendency of this peptide was also associated with an increased ability to aggregate into amyloid-like fibrils. These results suggest that methionine at position 129 of the prion protein increases its susceptibility to switch to the abnormal conformation, in comparison with the presence of valine at the same position. (C) 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:451 / 456
页数:6
相关论文
共 50 条
[1]   PRION PROTEIN ISOFORMS, A CONVERGENCE OF BIOLOGICAL AND STRUCTURAL INVESTIGATIONS [J].
BALDWIN, MA ;
COHEN, FE ;
PRUSINER, SB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (33) :19197-19200
[2]   Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides [J].
Chabry, J ;
Caughey, B ;
Chesebro, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (21) :13203-13207
[3]   EMPIRICAL PREDICTIONS OF PROTEIN CONFORMATION [J].
CHOU, PY ;
FASMAN, GD .
ANNUAL REVIEW OF BIOCHEMISTRY, 1978, 47 :251-276
[4]   Pathologic conformations of prion proteins [J].
Cohen, FE ;
Prusiner, SB .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :793-+
[5]   GENETIC PREDISPOSITION TO IATROGENIC CREUTZFELDT-JAKOB DISEASE [J].
COLLINGE, J ;
PALMER, MS ;
DRYDEN, AJ .
LANCET, 1991, 337 (8755) :1441-1442
[6]   Prion diseases of humans and animals: Their causes and molecular basis [J].
Collinge, J .
ANNUAL REVIEW OF NEUROSCIENCE, 2001, 24 :519-550
[7]  
Cortelli P, 1999, J SLEEP RES, V8, P23
[8]  
DEGIOIA L, 1994, J BIOL CHEM, V269, P7859
[9]   Structure of the recombinant full-length hamster prion protein PrP(29-231): The N terminus is highly flexible [J].
Donne, DG ;
Viles, JH ;
Groth, D ;
Mehlhorn, I ;
James, TL ;
Cohen, FE ;
Prusiner, SB ;
Wright, PE ;
Dyson, HJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (25) :13452-13457
[10]   NEUROTOXICITY OF A PRION PROTEIN-FRAGMENT [J].
FORLONI, G ;
ANGERETTI, N ;
CHIESA, R ;
MONZANI, E ;
SALMONA, M ;
BUGIANI, O ;
TAGLIAVINI, F .
NATURE, 1993, 362 (6420) :543-546